Log in

NASDAQ:FPRXFive Prime Therapeutics News Headlines

$5.43
+0.13 (+2.45 %)
(As of 05/25/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.26
Now: $5.43
$5.60
50-Day Range
$2.14
MA: $3.39
$5.43
52-Week Range
$1.75
Now: $5.43
$9.13
Volume311,890 shs
Average Volume405,966 shs
Market Capitalization$198.90 million
P/E RatioN/A
Dividend YieldN/A
Beta2.78

Headlines

Five Prime Therapeutics (NASDAQ FPRX) News Headlines

Source:
DateHeadline
Five Prime Therapeutics Inc (NASDAQ:FPRX) Short Interest UpdateFive Prime Therapeutics Inc (NASDAQ:FPRX) Short Interest Update
www.americanbankingnews.com - May 22 at 1:01 PM
Five Prime Therapeutics Inc (NASDAQ:FPRX) Major Shareholder Purchases $1,203,706.70 in StockFive Prime Therapeutics Inc (NASDAQ:FPRX) Major Shareholder Purchases $1,203,706.70 in Stock
www.americanbankingnews.com - May 18 at 9:52 PM
Wedbush Research Analysts Cut Earnings Estimates for Five Prime Therapeutics Inc (NASDAQ:FPRX)Wedbush Research Analysts Cut Earnings Estimates for Five Prime Therapeutics Inc (NASDAQ:FPRX)
www.americanbankingnews.com - May 18 at 1:30 AM
Five Prime Therapeutics Inc (NASDAQ:FPRX) Expected to Announce Quarterly Sales of $4.43 MillionFive Prime Therapeutics Inc (NASDAQ:FPRX) Expected to Announce Quarterly Sales of $4.43 Million
www.americanbankingnews.com - May 17 at 1:34 AM
Zacks: Brokerages Anticipate Five Prime Therapeutics Inc (NASDAQ:FPRX) to Announce -$0.69 Earnings Per ShareZacks: Brokerages Anticipate Five Prime Therapeutics Inc (NASDAQ:FPRX) to Announce -$0.69 Earnings Per Share
www.americanbankingnews.com - May 15 at 10:23 PM
Is Five Prime Therapeutics (FPRX) Stock a Solid Choice Right Now?Is Five Prime Therapeutics (FPRX) Stock a Solid Choice Right Now?
finance.yahoo.com - May 15 at 1:05 PM
Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Just Reported And Analysts Have Been Cutting Their EstimatesFive Prime Therapeutics, Inc. (NASDAQ:FPRX) Just Reported And Analysts Have Been Cutting Their Estimates
finance.yahoo.com - May 10 at 4:10 PM
Five Prime Therapeutics, Inc. (FPRX) CEO Thomas Civik on Q1 2020 Results - Earnings Call TranscriptFive Prime Therapeutics, Inc. (FPRX) CEO Thomas Civik on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 12:54 AM
Edited Transcript of FPRX earnings conference call or presentation 7-May-20 8:30pm GMTEdited Transcript of FPRX earnings conference call or presentation 7-May-20 8:30pm GMT
finance.yahoo.com - May 8 at 8:47 PM
Five Prime Therapeutics EPS beats by $0.11, beats on revenueFive Prime Therapeutics EPS beats by $0.11, beats on revenue
seekingalpha.com - May 8 at 2:58 AM
Five Prime Therapeutics Inc (NASDAQ:FPRX) Receives Consensus Recommendation of "Hold" from AnalystsFive Prime Therapeutics Inc (NASDAQ:FPRX) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - May 7 at 6:16 PM
Five Prime Therapeutics Reports First Quarter 2020 ResultsFive Prime Therapeutics Reports First Quarter 2020 Results
finance.yahoo.com - May 7 at 4:57 PM
Five Prime Therapeutics Inc (NASDAQ:FPRX) Short Interest Up 9.4% in AprilFive Prime Therapeutics Inc (NASDAQ:FPRX) Short Interest Up 9.4% in April
www.americanbankingnews.com - May 2 at 2:01 PM
Five Prime Therapeutics (FPRX) Set to Announce Earnings on ThursdayFive Prime Therapeutics (FPRX) Set to Announce Earnings on Thursday
www.americanbankingnews.com - May 1 at 3:51 PM
Five Prime Therapeutics Announces Timing of Its First Quarter 2020 Results Conference CallFive Prime Therapeutics Announces Timing of Its First Quarter 2020 Results Conference Call
finance.yahoo.com - April 30 at 6:50 PM
FPRX Five Prime Therapeutics, Inc. Common StockFPRX Five Prime Therapeutics, Inc. Common Stock
www.nasdaq.com - April 25 at 7:23 PM
Five Prime Therapeutics Changes 2020 Annual Meeting to Virtual FormatFive Prime Therapeutics Changes 2020 Annual Meeting to Virtual Format
finance.yahoo.com - April 22 at 7:33 PM
Five Prime Therapeutics names new CEOFive Prime Therapeutics names new CEO
seekingalpha.com - April 14 at 1:49 PM
Five Prime Therapeutics Appoints Tom Civik as Chief Executive OfficerFive Prime Therapeutics Appoints Tom Civik as Chief Executive Officer
finance.yahoo.com - April 14 at 1:49 PM
Here's Why Five Prime Therapeutics (NASDAQ:FPRX) Must Use Its Cash WiselyHere's Why Five Prime Therapeutics (NASDAQ:FPRX) Must Use Its Cash Wisely
finance.yahoo.com - April 9 at 8:42 AM
Edited Transcript of FPRX earnings conference call or presentation 27-Feb-20 9:30pm GMTEdited Transcript of FPRX earnings conference call or presentation 27-Feb-20 9:30pm GMT
finance.yahoo.com - March 18 at 6:54 PM
Five Prime Therapeutics Announces Publication of the Phase 1 Bemarituzumab Study in the Journal of Clinical OncologyFive Prime Therapeutics Announces Publication of the Phase 1 Bemarituzumab Study in the Journal of Clinical Oncology
www.businesswire.com - March 13 at 9:50 AM
Five Prime Therapeutics, Inc. (FPRX) CEO William Ringo on Q4 2019 Results - Earnings Call TranscriptFive Prime Therapeutics, Inc. (FPRX) CEO William Ringo on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - February 27 at 10:58 PM
Five Prime Therapeutics (FPRX) Reports Q4 Loss, Misses Revenue EstimatesFive Prime Therapeutics (FPRX) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - February 27 at 10:58 PM
Five Prime Therapeutics Reports Fourth Quarter and Full Year 2019 ResultsFive Prime Therapeutics Reports Fourth Quarter and Full Year 2019 Results
www.businesswire.com - February 27 at 5:57 PM
Five Prime Therapeutics EPS beats by $0.07, misses on revenueFive Prime Therapeutics EPS beats by $0.07, misses on revenue
seekingalpha.com - February 27 at 5:57 PM
Five Prime Therapeutics (FPRX) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseFive Prime Therapeutics (FPRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - February 20 at 5:31 PM
BRIEF-Five Prime Therapeutics Licenses Antibodies To Seattle Genetics For Use In Novel Antibody Drug Conjugate ProgramsBRIEF-Five Prime Therapeutics Licenses Antibodies To Seattle Genetics For Use In Novel Antibody Drug Conjugate Programs
www.msn.com - February 19 at 2:40 PM
Five Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) ProgramsFive Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) Programs
finance.yahoo.com - February 19 at 2:40 PM
Five Prime down 4% on failed cabiralizumab studyFive Prime down 4% on failed cabiralizumab study
seekingalpha.com - February 18 at 1:24 PM
Five Prime Therapeutics: Management Shakeup, Activist Investor, Valued At Cash, Ripe For A Turnaround In 2020Five Prime Therapeutics: Management Shakeup, Activist Investor, Valued At Cash, Ripe For A Turnaround In 2020
seekingalpha.com - February 18 at 1:24 PM
Five Prime Therapeutics Provides Update on Phase 2 Trial of Cabiralizumab Combined with Opdivo ® in Pancreatic CancerFive Prime Therapeutics Provides Update on Phase 2 Trial of Cabiralizumab Combined with Opdivo ® in Pancreatic Cancer
www.businesswire.com - February 18 at 1:24 PM
Five Prime Therapeutics Provides Update on Phase 2 Trial of Cabiralizumab Combined with Opdivo® in Pancreatic CancerFive Prime Therapeutics Provides Update on Phase 2 Trial of Cabiralizumab Combined with Opdivo® in Pancreatic Cancer
finance.yahoo.com - February 18 at 1:24 PM
Five Prime Therapeutics Announces Timing of Its Fourth Quarter and Full Year 2019 Results Conference CallFive Prime Therapeutics Announces Timing of Its Fourth Quarter and Full Year 2019 Results Conference Call
finance.yahoo.com - February 13 at 7:56 PM
Five Prime Therapeutics (FPRX) Presents At 38th Annual J.P. Morgan Healthcare Conference - SlideshowFive Prime Therapeutics (FPRX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 17 at 1:41 PM
An Activist Fund Has Been Buying Five Prime PharmaAn Activist Fund Has Been Buying Five Prime Pharma
seekingalpha.com - January 17 at 8:41 AM
Five Prime Therapeutics: An Activist Fund Owns 22% Of This BiotechFive Prime Therapeutics: An Activist Fund Owns 22% Of This Biotech
seekingalpha.com - January 16 at 1:23 PM
If You Had Bought Five Prime Therapeutics (NASDAQ:FPRX) Stock Three Years Ago, Youd Be Sitting On A 89% Loss, TodayIf You Had Bought Five Prime Therapeutics (NASDAQ:FPRX) Stock Three Years Ago, You'd Be Sitting On A 89% Loss, Today
finance.yahoo.com - January 10 at 5:00 PM
If You Had Bought Five Prime Therapeutics (NASDAQ:FPRX) Stock Three Years Ago, You'd Be Sitting On A 89% Loss, TodayIf You Had Bought Five Prime Therapeutics (NASDAQ:FPRX) Stock Three Years Ago, You'd Be Sitting On A 89% Loss, Today
finance.yahoo.com - January 10 at 5:00 PM
Five Prime Therapeutics to Participate in the 38th Annual J.P. Morgan Healthcare ConferenceFive Prime Therapeutics to Participate in the 38th Annual J.P. Morgan Healthcare Conference
www.businesswire.com - December 30 at 1:13 PM
Five Prime Therapeutics Announces Resignation of Dr. Lewis T. "Rusty" Williams From Board of DirectorsFive Prime Therapeutics Announces Resignation of Dr. Lewis T. "Rusty" Williams From Board of Directors
finance.yahoo.com - December 27 at 6:08 PM
Five Prime founder leaves board to focus on startupFive Prime founder leaves board to focus on startup
seekingalpha.com - December 26 at 8:37 PM
Five Prime Therapeutics Announces Resignation of Dr. Lewis T. “Rusty” Williams From Board of DirectorsFive Prime Therapeutics Announces Resignation of Dr. Lewis T. “Rusty” Williams From Board of Directors
www.businesswire.com - December 26 at 8:37 PM
Five Prime Therapeutics Announces Resignation of Dr. Lewis T. "Rusty" Williams From Board of DirectorsFive Prime Therapeutics Announces Resignation of Dr. Lewis T. "Rusty" Williams From Board of Directors
finance.yahoo.com - December 26 at 8:37 PM
Head of big South San Francisco biotech thriving in first CEO roleHead of big South San Francisco biotech thriving in first CEO role
finance.yahoo.com - December 20 at 6:34 PM
Is Five Prime Therapeutics Inc (FPRX) A Good Stock To Buy ?Is Five Prime Therapeutics Inc (FPRX) A Good Stock To Buy ?
finance.yahoo.com - December 10 at 2:41 PM
Our Take On Five Prime TherapeuticsOur Take On Five Prime Therapeutics
seekingalpha.com - November 18 at 3:59 PM
Edited Transcript of FPRX earnings conference call or presentation 6-Nov-19 9:30pm GMTEdited Transcript of FPRX earnings conference call or presentation 6-Nov-19 9:30pm GMT
finance.yahoo.com - November 12 at 1:19 PM
Five Prime Therapeutics Presents Initial Safety Data from the Phase 1 Trial of FPT155 at the Society for Immunotherapy of Cancer Annual MeetingFive Prime Therapeutics Presents Initial Safety Data from the Phase 1 Trial of FPT155 at the Society for Immunotherapy of Cancer Annual Meeting
finance.yahoo.com - November 9 at 10:28 AM
Five Prime Therapeutics, Inc. (FPRX) CEO William Ringo on Q3 2019 Results - Earnings Call TranscriptFive Prime Therapeutics, Inc. (FPRX) CEO William Ringo on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 6 at 11:51 PM
This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.